Skip to main content

AI Bias Analysis

4 models · Takes ~15 seconds

MedPage Today

FDA Expands Stelara Approval; Liver Cancer Blood Test; Pharmacotherapy for MASLD

FDA Expands Stelara Approval; Liver Cancer Blood Test; Pharmacotherapy for MASLD
ShareXFacebook

(MedPage Today) -- The FDA expanded the approval of ustekinumab (Stelara) in Crohn's disease to include the treatment of kids as young as 2 years, Johnson & Johnson announced. High clinical remission rates (98%) at approximately 5 years were...

M

Source

MedPage Today

Read full article at MedPage Today

Opens original article in a new tab

Advertisement

Related Health Stories

Advertisement